Childrens Hospital of the Kings Daughters INC
Childrens Hospital of the Kings Daughters INC was paid $10.18M by Medicaid between Jan 2018 and Jun 2024, across 159 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 25% of everything it billed.
NORFOLK, VA 23507
Next to other Adolescent and Children Mental Health Clinic/Center providers in Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,539 | $424K | |
| 2019 | 77,507 | $1.44M | |
| 2020 | 71,446 | $2.63M | |
| 2021 | 89,740 | $2.94M | |
| 2022 | 77,150 | $2.60M | |
| 2023 | 1,405 | $124K | |
| 2024incomplete | 203 | $23K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 25% | 41,844 | 13,544 | $2.52M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 19,838 | 19,284 | $1.85M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 16% | 36,589 | 10,338 | $1.65M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 7.6% | 23,646 | 7,659 | $778K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 5.7% | 256 | 231 | $582K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.4% | 6,602 | 6,447 | $450K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.5% | 2,426 | 2,370 | $358K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.6% | 4,814 | 1,957 | $159K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 1,509 | 1,485 | $150K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.0% | 1,031 | 1,009 | $105K |
| 97161 | <1% | 1,981 | 1,923 | $99K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 876 | 795 | $97K |
147 more codes
| 90837 | Psychotherapy session, about an hour | <1% | 1,016 | $95K |
| 97162 | <1% | 1,820 | $91K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,279 | $89K |
| 92526 | <1% | 1,420 | $85K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 2,288 | $76K |
| 92587 | <1% | 3,298 | $70K | |
| 92579 | <1% | 1,421 | $64K | |
| 97116 | <1% | 2,612 | $62K | |
| 97542 | <1% | 927 | $61K | |
| 92567 | <1% | 3,859 | $58K | |
| 97165 | <1% | 1,342 | $58K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,757 | $46K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 331 | $41K |
| 64643 | <1% | 296 | $32K | |
| 64642 | <1% | 305 | $32K | |
| 97760 | <1% | 381 | $27K | |
| 97016 | <1% | 966 | $25K | |
| 87631 | <1% | 4,687 | $25K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 402 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,926 | $17K |
| 94010 | <1% | 1,807 | $15K | |
| 97763 | <1% | 573 | $15K | |
| 97014 | <1% | 670 | $14K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,673 | $12K |
| 96112 | <1% | 65 | $10K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 129 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,832 | $9K |
| 80053 | Comprehensive metabolic panel | <1% | 8,018 | $9K |
| 93304 | <1% | 276 | $9K | |
| 80050 | General health panel | <1% | 3,277 | $9K |
| 96127 | <1% | 1,365 | $8K | |
| 99205 | Prolong outpt/office vis | <1% | 53 | $8K |
| 97010 | <1% | 4,238 | $8K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 4,845 | $7K |
| 93321 | <1% | 938 | $6K | |
| 87486 | <1% | 4,688 | $6K | |
| 87581 | <1% | 4,690 | $6K | |
| 93325 | <1% | 2,021 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 141 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 7,222 | $5K |
| 92552 | <1% | 169 | $5K | |
| 80061 | Lipid panel | <1% | 6,713 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,076 | $5K |
| 87507 | <1% | 380 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 5,098 | $5K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 76 | $5K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 807 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,860 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,969 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,300 | $4K |
| 96160 | <1% | 1,170 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,126 | $3K |
| 84439 | <1% | 4,706 | $3K | |
| 92556 | <1% | 80 | $3K | |
| 83020 | <1% | 1,032 | $3K | |
| 82728 | <1% | 2,295 | $3K | |
| 97033 | <1% | 112 | $3K | |
| 97750 | <1% | 30 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 59 | $2K |
| 95117 | <1% | 178 | $2K | |
| 93227 | <1% | 98 | $2K | |
| 97755 | <1% | 12 | $2K | |
| V5266 | Battery for use in hearing device | <1% | 269 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,296 | $2K |
| 82248 | <1% | 2,731 | $2K | |
| 87077 | <1% | 1,847 | $2K | |
| 83516 | <1% | 1,825 | $2K | |
| 85045 | <1% | 2,525 | $2K | |
| 82977 | <1% | 2,655 | $2K | |
| 80306 | <1% | 1,019 | $2K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 13 | $2K |
| 99170 | <1% | 13 | $2K | |
| 83735 | <1% | 1,028 | $2K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 23 | $1K |
| 82784 | <1% | 1,948 | $1K | |
| 82570 | <1% | 2,401 | $1K | |
| 84100 | <1% | 1,249 | $1K | |
| 96111 | <1% | 13 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,076 | $1K |
| 82043 | <1% | 1,606 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,472 | $1K |
| V5011 | Fitting/orientation/checking of hearing aid | <1% | 14 | $1K |
| 86003 | <1% | 574 | $1K | |
| 99283 | Emergency room visit (moderate) | <1% | 19 | $983.34 |
| 87186 | <1% | 1,275 | $939.74 | |
| 83550 | <1% | 807 | $891.00 | |
| 84460 | <1% | 747 | $855.95 | |
| 82247 | <1% | 1,882 | $839.65 | |
| 83540 | <1% | 1,038 | $828.14 | |
| 84450 | <1% | 745 | $785.00 | |
| 82565 | <1% | 577 | $709.39 | |
| 85027 | <1% | 1,017 | $702.88 | |
| 81025 | <1% | 986 | $682.00 | |
| 84146 | <1% | 348 | $587.16 | |
| 86140 | <1% | 2,719 | $554.87 | |
| 81001 | <1% | 2,075 | $530.45 | |
| 81003 | <1% | 3,201 | $529.71 | |
| 83655 | <1% | 4,206 | $519.19 | |
| 87070 | <1% | 863 | $517.02 | |
| 87506 | <1% | 14 | $473.38 | |
| 80076 | <1% | 548 | $433.68 | |
| 83001 | <1% | 343 | $372.05 | |
| 85610 | <1% | 571 | $367.87 | |
| 85652 | <1% | 2,661 | $325.38 | |
| 83970 | <1% | 24 | $297.20 | |
| 85007 | <1% | 656 | $287.42 | |
| 86480 | <1% | 105 | $278.90 | |
| 87660 | <1% | 277 | $266.82 | |
| 87480 | <1% | 277 | $252.70 | |
| 87510 | <1% | 277 | $252.70 | |
| 90785 | <1% | 18 | $237.24 | |
| 86038 | <1% | 422 | $217.67 | |
| 83002 | <1% | 291 | $216.71 | |
| 87101 | <1% | 331 | $208.20 | |
| 84156 | <1% | 750 | $204.96 | |
| 83615 | <1% | 157 | $202.48 | |
| 84550 | <1% | 364 | $195.36 | |
| 84402 | <1% | 163 | $160.44 | |
| 86592 | <1% | 1,395 | $109.28 | |
| 85730 | <1% | 155 | $100.97 | |
| 83690 | <1% | 258 | $81.29 | |
| 83519 | <1% | 13 | $66.24 | |
| 80197 | <1% | 15 | $49.44 | |
| 82465 | <1% | 260 | $39.20 | |
| 86803 | <1% | 67 | $38.52 | |
| 87340 | <1% | 75 | $37.20 | |
| 83993 | <1% | 17 | $35.34 | |
| 82785 | <1% | 115 | $32.92 | |
| 85018 | <1% | 908 | $31.95 | |
| 80324 | <1% | 25 | $27.28 | |
| 82670 | <1% | 119 | $25.15 | |
| 82150 | <1% | 114 | $17.49 | |
| 86665 | <1% | 13 | $16.33 | |
| 82947 | <1% | 24 | $14.16 | |
| 87807 | <1% | 74 | $11.79 | |
| 86706 | <1% | 67 | $9.67 | |
| 82272 | <1% | 17 | $7.62 | |
| 82550 | <1% | 29 | $5.86 | |
| 85660 | <1% | 12 | $4.96 | |
| J2357 | Injection, omalizumab, 5 mg | <1% | 15 | $0.16 |
| 36415 | Collection of venous blood by venipuncture | 0% | 58 | $0.00 |
| 97113 | 0% | 50 | $0.00 | |
| 82607 | 0% | 13 | $0.00 | |
| 86225 | 0% | 24 | $0.00 | |
| 84030 | 0% | 67 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 12 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.